Brief: Philips Receives FDA 510(K) Clearance For Its Rembra Platform
April 22 (Reuters) - Koninklijke Philips NV PHG.AS: PHILIPS RECEIVES FDA 510(K) CLEARANCE FOR ITS REMBRA PLATFORM, EXPANDING ACCESS TO FASTER, MORE PRECISE CT IMAGING ACROSS FRONTLINE CARE AND CANCER TREATMENT PLANNING Source text: ID:nGNX9vyLmd Further company coverage: PHG.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Koninklijke Philips
See all newsEurope Research Roundup: Asos, Erste Group, SCHOTT pharma
Europe Research Roundup: Acceler8 Ventures, Hermes, Soitec
Philips rises after beating adjusted EBITA estimates
Koninklijke Philips N.V. reports results for the quarter ended September 30 - Earnings Summary
Philips reaches DOJ agreement over device recall, books €288 million provision in Q3 (updated)